BRPI0506689A - composições compreendendo memantina e polìmeros polianiÈnicos para administração ao olho - Google Patents

composições compreendendo memantina e polìmeros polianiÈnicos para administração ao olho

Info

Publication number
BRPI0506689A
BRPI0506689A BRPI0506689-1A BRPI0506689A BRPI0506689A BR PI0506689 A BRPI0506689 A BR PI0506689A BR PI0506689 A BRPI0506689 A BR PI0506689A BR PI0506689 A BRPI0506689 A BR PI0506689A
Authority
BR
Brazil
Prior art keywords
compositions
memantine
administration
eye
polyanionic polymers
Prior art date
Application number
BRPI0506689-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Patrick M Hughes
Orest Olejnik
Rhett M Schiffman
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/752,125 external-priority patent/US20050147584A1/en
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0506689A publication Critical patent/BRPI0506689A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0506689-1A 2004-01-05 2005-01-04 composições compreendendo memantina e polìmeros polianiÈnicos para administração ao olho BRPI0506689A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/752,125 US20050147584A1 (en) 2004-01-05 2004-01-05 Compositions and methods comprising memantine and polyanionic polymers
US10/941,272 US20050031652A1 (en) 2003-02-25 2004-09-14 Compositions and methods comprising memantine and polyanionic polymers
PCT/US2005/000249 WO2005067891A1 (en) 2004-01-05 2005-01-04 Compositions comprosing memantine and polyanionic polymers for administration to the eye

Publications (1)

Publication Number Publication Date
BRPI0506689A true BRPI0506689A (pt) 2007-05-02

Family

ID=34798997

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0506689-1A BRPI0506689A (pt) 2004-01-05 2005-01-04 composições compreendendo memantina e polìmeros polianiÈnicos para administração ao olho

Country Status (7)

Country Link
US (1) US20050031652A1 (https=)
EP (1) EP1701700A1 (https=)
JP (1) JP2007517885A (https=)
AU (1) AU2005204365A1 (https=)
BR (1) BRPI0506689A (https=)
CA (1) CA2552521A1 (https=)
WO (1) WO2005067891A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009884A1 (en) * 1997-06-30 2005-01-13 Dreyer Evan B. Calcium blockers to treat proliferative retinal diseases
JP2002182418A (ja) * 2000-12-11 2002-06-26 Konica Corp 画像形成方法、画像形成装置
US20080033053A1 (en) * 2004-07-22 2008-02-07 Wolfgang Curt D Cross-Reference To Related Applications
EP1776097A1 (en) * 2004-07-26 2007-04-25 Allergan, Inc. Methods of treating ophthalmic conditions
US20070167527A1 (en) * 2006-01-13 2007-07-19 Burke James A Memantine for the normalization of visual acuity deficits
JP5373613B2 (ja) 2006-10-16 2013-12-18 バイオノミクス リミテッド 新規な抗不安薬化合物
US10954231B2 (en) 2006-10-16 2021-03-23 Bionomics Limited Anxiolytic compounds
WO2008098027A2 (en) * 2007-02-06 2008-08-14 Allergan, Inc. Treatment of ischemic retinal conditions with memantine
EP2509596B1 (en) 2009-12-08 2019-08-28 Case Western Reserve University Gamma aminoacids for treating ocular disorders
CA2828780A1 (en) 2011-03-02 2012-09-07 Bionomics Limited Novel small-molecules as therapeutics
EP2707367B1 (en) 2011-05-12 2019-10-09 Bionomics Limited Methods for preparing naphthyridines

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554367A (en) * 1984-10-31 1996-09-10 Alcon Laboratories, Inc. Compositions for treatment of glaucoma
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
US4738851A (en) * 1985-09-27 1988-04-19 University Of Iowa Research Foundation, Inc. Controlled release ophthalmic gel formulation
US5008242A (en) * 1986-12-24 1991-04-16 John Lezdey Treatment of inflammation using 1-antichymotrypsin
US5221696A (en) * 1989-03-29 1993-06-22 Alcon Laboratories, Inc. Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
US5922773A (en) * 1992-12-04 1999-07-13 The Children's Medical Center Corp. Glaucoma treatment
US5691316A (en) * 1994-06-01 1997-11-25 Hybridon, Inc. Cyclodextrin cellular delivery system for oligonucleotides
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
EP0994709A4 (en) * 1997-06-30 2006-02-01 Allergan Inc CALCIUM BLOCKER FOR THE TREATMENT OF PROLIFERATIVE VITREORETINOPATHY
US6509355B1 (en) * 1998-10-27 2003-01-21 Alcon Laboratories, Inc. Treatment of disorders of the outer retina
US6258350B1 (en) * 1999-01-20 2001-07-10 Alcon Manufacturing, Ltd. Sustained release ophthalmic formulation
HK1040184A1 (zh) * 1999-03-12 2002-05-31 Alcon Laboratories, Inc. 治療青光眼之組合療法
US6482854B1 (en) * 1999-03-25 2002-11-19 Massachusetts Eye And Ear Infirmary Glaucoma treatment
SK282717B6 (sk) * 2000-03-10 2002-11-06 �Stav Experiment�Lnej Farmakol�Gie Sav Spôsob prípravy ultravysokomolekulových hyalurónanov
US6572849B2 (en) * 2000-09-20 2003-06-03 Lee Shahinian, Jr. Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications
US6761694B2 (en) * 2001-12-13 2004-07-13 Allergan, Inc. Methods for measuring retinal damage
US6982079B2 (en) * 2002-04-26 2006-01-03 Allergan, Inc. Compositions for treating hyperemia
CA2534484A1 (en) * 2003-08-07 2005-02-17 Allergan, Inc. Compositions for delivery of therapeutics into the eyes and methods for making and using same

Also Published As

Publication number Publication date
EP1701700A1 (en) 2006-09-20
US20050031652A1 (en) 2005-02-10
AU2005204365A1 (en) 2005-07-28
WO2005067891A1 (en) 2005-07-28
JP2007517885A (ja) 2007-07-05
CA2552521A1 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
MX2022001541A (es) Composiciones farmaceuticas y metodos para contrarrestar la cardiotoxicidad inducida por quimioterapia.
BRPI0709581A8 (pt) compostos de bicicloeteroarila como moduladores de px27 e seu uso
AR044007A1 (es) Metodos para el tratamiento de la enfermedad de parkinson
BR112013004436A2 (pt) composições e usos de materiais com atividade microbicida alta e toxicidade baixa
BRPI0411900B8 (pt) compostos e composições farmacêuticas compreendendo os mesmos
BRPI0518542A2 (pt) regimes para viscossuplementaÇço intra-articular
BR112013026032A2 (pt) composições nutricionais incluindo ácidos graxos de cadeia ramificada para cicatrização de ferida
BR0013010B1 (pt) Formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina
BRPI0411016A (pt) composições antisépticas, processos e sistemas
CY1106476T1 (el) Υποκατεστημενες διυδροκιναζολινες με αντι-ιικες ιδιοτητες
BR112015023922A2 (pt) composição farmacêutica compreendendo um ativador de ampk e um agente serotonérgico e métodos de uso destes
GT200100183A (es) Derivados de quinolina y quinazolina.
BRPI0416032A (pt) excipientes em veìculos de distribuição de fármacos
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
BR0210139A (pt) Composições farmacêuticas
HK1206297A1 (en) Pharmaceutical compositions for combination therapy
BRPI0510931A (pt) derivados de sulfamato e sulfamida para o tratamento de epilepsia e distúrbios relacionados
BRPI0418166A (pt) compostos de bicicloeteroarilamina como ligandos de canal de ìon e usos destes
DOP2009000165A (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos
BRPI0506689A (pt) composições compreendendo memantina e polìmeros polianiÈnicos para administração ao olho
EA200970081A1 (ru) Соединения, обладающие потенциирующим действием в отношении активности этионамида, и их применения
BRPI0606112B8 (pt) 3-hetero-aril-3-hidróxi-2-amino-propil aminas e compostos relacionados com atividade analgésica, uso dos mesmos e composição farmacêutica compreendendo os mesmos
CO6361950A2 (es) Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1
NO20082097L (no) Farmasoytiske sammensetninger
BR112013010829B8 (pt) Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2099 DE 29/03/2011.